Viewing SEC Facts Units
Company Name:
Revance Therapeutics, Inc.
CIK:
1479290
Start Filing Date:
2014-07-01
End Filing Date:
2014-09-30
ACCN:
0001193125-14-411349
Value:
$ 23,331,104
Value Error:
$ None
Created By:
Date Filed:
2014-11-13
FY:
2014
Fiscal Period:
Q3
Frame:
CY2013Q3
Type:
us-gaap
Form:
10-Q
Units:
shares